top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hCD39 MC38
Common name
B-hCD39 MC38 Catalog number     311521
Aliases ENTPD1 Disease  Colon carcinoma
Organism
Mouse
Strain  C57BL/6
Tissue types Colon Tissue  Colon

Description 

Human CD39 is highly expressed on the surface of B-hCD39 MC38 cells.

Targeting strategy

Gene targeting strategy for B-hCD39 MC38 cells. The exogenous promoter and human CD39 coding sequence were inserted into the targeting vector used in the lentivirus system. 

Protein expression analysis

from clipboard


CD39 and EGFP expression analysis in B-hCD39 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hCD39 MC38 cultures were stained with species-specific anti-CD39 antibody. Human CD39 was detected on the surface of B-hCD39 MC38 cells but not wild-type MC38 cells. EGFP was detected in B-hCD39 MC38 cells but not wild-type MC38 cells. The 1-F07 clone of B-hCD39 MC38 cells was used for in vivo experiments.


Tumor growth curve & Body weight changes


from clipboard


Subcutaneous homograft tumor growth of B-hCD39 MC38 cells. B-hCD39 MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hCD39 mice (female, 7-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD39 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.



Protein expression analysis of tumor cells


from clipboard



B-hCD39 MC38 cells were subcutaneously transplanted into B-hCD39 mice (n=6), and on 31 days post inoculation, tumor cells were harvested and assessed for human CD39 expression by flow cytometry. As shown, human CD39 was highly expressed on the surface of tumor cells. Therefore, B-hCD39 MC38 cells can be used for in vivo efficacy studies of novel CD39 therapeutics.



Tumor growth curve & Body weight changes


from clipboard


Subcutaneous homograft tumor growth of B-hCD39 MC38 cells. B-hCD39 MC38 cells (5x105, 1x106, 5x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hPD-1/hCD39 mice (female, 9-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD39 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Protein expression analysis of tumor cells


from clipboard



B-hCD39 MC38 cells were subcutaneously transplanted into B-hPD-1/hCD39 mice (n=5), and on 27 days post inoculation, tumor cells were harvested and assessed for human CD39 expression by flow cytometry. As shown, human CD39 was highly expressed on the surface of tumor cells. Therefore, B-hCD39 MC38 cells can be used for in vivo efficacy studies of novel CD39 therapeutics.